Paul Balmer

3.3k total citations
91 papers, 2.5k citations indexed

About

Paul Balmer is a scholar working on Epidemiology, Microbiology and Immunology. According to data from OpenAlex, Paul Balmer has authored 91 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Epidemiology, 70 papers in Microbiology and 11 papers in Immunology. Recurrent topics in Paul Balmer's work include Pneumonia and Respiratory Infections (76 papers), Bacterial Infections and Vaccines (70 papers) and Respiratory viral infections research (24 papers). Paul Balmer is often cited by papers focused on Pneumonia and Respiratory Infections (76 papers), Bacterial Infections and Vaccines (70 papers) and Respiratory viral infections research (24 papers). Paul Balmer collaborates with scholars based in United Kingdom, United States and France. Paul Balmer's co-authors include Ray Borrow, Emma Parker Miller, Elizabeth Miller, Jamie Findlow, Laura J. York, Nick Andrews, Myint Tin Tin Htar, Elaine Stanford, Maureen Dawson and Lidia Serra and has published in prestigious journals such as SHILAP Revista de lepidopterología, Infection and Immunity and The Lancet Infectious Diseases.

In The Last Decade

Paul Balmer

89 papers receiving 2.4k citations

Peers

Countries citing papers authored by Paul Balmer

Since Specialization

Citations

This map shows the geographic impact of Paul Balmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Balmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Balmer more than expected).

Fields of papers citing papers by Paul Balmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Balmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Balmer. The network helps show where Paul Balmer may publish in the future.

Co-authorship network of co-authors of Paul Balmer

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Balmer. A scholar is included among the top collaborators of Paul Balmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Balmer. Paul Balmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Invasive Meningococcal Disease in the Post-COVID World: Patterns of Disease Rebound 2025 ·Vaccines ·Jamie Findlow, Myint Tin Tin Htar, Rodolfo Villena, Paul Balmer	3
2	A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix® Vaccine When Given to Healthy Infants at 3 and 12 Months of Age 2025 ·Infectious Diseases and Therapy ·(unknown), Federico Martinón‐Torres, Mika Rämet, (unknown), Ryan Newton, Roger Maansson, Mark Cutler, Paula Peyrani, Jamie Findlow, Paul Balmer, Luis Jódar, William C. Gruber, Annaliesa S. Anderson, Johannes Beeslaar	0
3	Global epidemiology of serogroup Y invasive meningococcal disease: a literature review 2024 ·Epidemiology and Infection ·Myint Tin Tin Htar, Jamie Findlow, Paul Balmer, David L. Swerdlow	2
4	Meningococcal Disease in the Post–COVID-19 Era: A Time to Prepare 2023 ·Infectious Diseases and Therapy ·David E. Bloom, Paolo Bonanni, Federico Martinón‐Torres, Peter Richmond, Marco Aurélio Palazzi Sáfadi, David Salisbury, (unknown), (unknown), Jamie Findlow, Paul Balmer	9
5	Epidemiology of invasive meningococcal disease worldwide from 2010–2019: a literature review 2023 ·Epidemiology and Infection ·(unknown), Myint Tin Tin Htar, Jamie Findlow, Paul Balmer	53
6	Broad vaccine protection against Neisseria meningitidis using factor H binding protein 2020 ·Vaccine ·Jamie Findlow, Christopher D. Bayliss, Peter T. Beernink, Ray Borrow, Paul Liberator, Paul Balmer	11
7	MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies 2020 ·Infectious Diseases and Therapy ·Johannes Beeslaar, Judith Absalon, Annaliesa S. Anderson, Joseph J. Eiden, Paul Balmer, Shannon L. Harris, Thomas R. Jones, Robert E. O’Neill, (unknown), David Radley, Roger Maansson, John Ginis, Amit Srivastava, John L. Perez	4
8	PCVs in individuals at increased risk of pneumococcal disease: a literature review 2015 ·Expert Review of Vaccines ·Mark A. Fletcher, Paul Balmer, É. Bonnet, Nathalie Dartois	16
9	The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children 2010 ·Critical Care ·Limangeni Mankhambo, Daniel L. Banda, (unknown), Graham Jeffers, Sarah White, Paul Balmer, Standwell C. Nkhoma, (unknown), Elizabeth Molyneux, C. Anthony Hart, Malcolm E. Molyneux, Robert S. Heyderman, Enitan D. Carrol	56
10	Immune response to pneumococcal conjugate vaccination in asplenic individuals 2009 ·Human Vaccines ·Elaine Stanford, (unknown), (unknown), Kenneth Lamden, (unknown), Nick Phin, David Baxter, MATTHEW HELBERT, Rosemary McCann, Nick Andrews, Paul Balmer, Ray Borrow, Edward B. Kaczmarski	31
11	Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005 2007 ·Vaccine ·Mehmet Ceyhan, İnci Yıldırım, Paul Balmer, Christine M. Riley, (unknown), Nick Andrews, Ray Borrow, Ayşegül Neşe Çıtak Kurt, Mehmet Turgut, (unknown), Çiğdem Ömür Ecevıt, (unknown), Viola Schultze	10
12	Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants 2006 ·Vaccine ·J. Rüggeberg, Clare L. Collins, Paul Clarke, (unknown), Ruchi Sinha, (unknown), John Chang, Elaine Stanford, Paul Balmer, Ray Borrow, Sarah A. Martin, Michael J. Robinson, E. Richard Moxon, Andrew J. Pollard, Paul T. Heath	43
13	Meningococcal surrogates of protection?serum bactericidal antibody activity 2005 ·Vaccine ·Ray Borrow, Paul Balmer, Emma Parker Miller	342
14	Serologic correlates of protection for evaluating the response to meningococcal vaccines 2004 ·Expert Review of Vaccines ·Paul Balmer, Ray Borrow	49
15	Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes 2004 ·Journal of Immunological Methods ·(unknown), Paul Balmer, Elaine Stanford, (unknown), (unknown), Ray Borrow	119
16	Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school children 2004 ·Vaccine ·Jamie Findlow, (unknown), (unknown), Paul Balmer, Germie van den Dobbelsteen, Maureen Dawson, Nick Andrews, Ray Borrow	16
17	Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants 2002 ·Vaccine ·(unknown), Ray Borrow, David Goldblatt, Paul Balmer, Maureen Dawson, Nick Andrews, Elizabeth Miller, Keith Cartwright	36
18	Interleukin‐4 influences the production of microfilariae in a mouse model of Brugia infection 2002 ·Parasite Immunology ·Eileen Devaney, Victoria Gillan, Isla Wheatley, (unknown), Richard A. O’Connor, Paul Balmer	20
19	Protective immunity to erythrocytic Plasmodium chabaudi AS infection involves IFNγ-mediated responses and a cellular infiltrate to the liver 2000 ·Parasitology ·Paul Balmer, James Alexander, R. S. Phillips	17
20	Antigenic variation during malaria infection—the contribution from the murine parasite Plasmodium chabaudi 1997 ·Parasite Immunology ·R. S. Phillips, (unknown), Paul Balmer, Pascal Neuville	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact